Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
about
Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence.Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptorsPeripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J miceCorticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors.Neuropeptide Y administration into the amygdala suppresses ethanol drinking in alcohol-preferring (P) rats following multiple deprivations.Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinkingNPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons.Differential modulation of ethanol-induced sedation and hypnosis by metabotropic glutamate receptor antagonists in C57BL/6J mice.Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non-ethanol-abstinent, Wistar rats.Addiction and arousal: the hypocretin connection.Distinct roles of the Y1 and Y2 receptors on neuropeptide Y-induced sensitization to sedation.Changes in expression of the neuropeptide Y Y1 receptor gene in the medial amygdala of transgenic mice during pregnancy and after delivery.Neuropeptide Y in the paraventricular nucleus of the hypothalamus increases ethanol intake in high- and low-alcohol-drinking rats.Neuropeptide Y Regulates Sleep by Modulating Noradrenergic Signaling.Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
P2860
Q26995739-2F0A61AE-2ABD-402E-814C-25D74FCCBE53Q28566254-33B9FA6F-42CE-47C7-8ADA-CA298EF1E4B5Q34333922-2BEE5278-612F-4D36-AD3D-158674198D47Q36733699-CB97961A-8886-42DB-BD7E-0891F82604FEQ36776154-23CDBF3E-F2AF-42AC-A5B9-253441CBEF64Q36784753-AB2C852C-B7ED-4D78-805E-56E3DEB32F39Q36850591-012E33F6-6931-4B12-B2B5-95023D8286E3Q36871587-3A70EDEB-B4A2-414D-A13B-C26EE0A68553Q37030341-B0E6AC63-1471-455C-89F1-3C6752462025Q37080576-204D332C-7DC6-48C6-A4EB-26DCAE1964EDQ43752317-9B2B6A35-C00B-4464-B514-8D5E4CBA3DA0Q44163276-89182A70-851C-41B1-A912-73BF01B1734FQ45185965-F8F307FA-7C75-48AB-86CB-F17ED5666283Q46248439-487DF292-10FA-4EB7-84C9-353CF20345D6Q48525452-793174D8-4506-4B75-98B3-D0F4CB45295C
P2860
Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
@en
Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
@nl
type
label
Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
@en
Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
@nl
prefLabel
Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
@en
Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
@nl
P2093
P2860
P50
P1476
Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism.
@en
P2093
Naveilhan P
Valjakka A
Vartiainen J
P2860
P304
P356
10.1046/J.0953-816X.2001.01601.X
P407
P577
2001-06-01T00:00:00Z